Epstein Secrets

rising from, or in connection with, the document. Japan: JPMorgan Securities Japan Co., Ltd. is regulated by the Financial Services Agency in Japan. Malaysia: This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bu

J.P.Morgan North America Equity Research O2 June 2014 • Merck & Co., Inc. Pushing Ahead Aggressively in PD-1 Development We attended Merck's ASCO analyst meeting today where the company reviewed new data and development plans for its PD-1 (pembrolizumab). Overall, we increasingly see M

rs who are stakeholders in public and global healthcare like UNFPA. USAID and Governments of Brazil and South Africa. Manufactured in Kuala Lumpur, Malaysia with a capacity of 100M units/year, FC2 already has and anticipates large orders that would bring in revenues in the coming years. FC2 is the only

r pulmonary arterial hypertension (PAH). The FDA approved Cialis for treating BPH in 2011. Finasteride (brand names: Proscar. Propecia) marketed by Merck is approved for treatment of enlarged prostate (>30 cc volume) as well as hair loss. Tadalafil can be used in combination with Finasteride can be u

utive Officer Chairman Chair and President Chairman Executive Chairman Chairman and Chief Executive Officer Chairman Khazanah Nasional Berhad Malaysia International Monetary Fund (IMF) The Sunday Telegraph The Uncultured Project LightSquared Holcim Ltd Dogus Group Consolidated Contractors C

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

IMF) The Uncultured Project LightSquared Holcim Ltd Dogus Group Consolidated Contractors Company (CCC) USA Switzerland United Arab Emirates Malaysia United Arab Emirates Nigeria USA India Canada Qatar Russian Federation Turkey Germany Germany South Africa USA USA USA Switzerland Sw

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

IMF) The Uncultured Project LightSquared Holcim Ltd Dogus Group Consolidated Contractors Company (CCC) USA Switzerland United Arab Emirates Malaysia United Arab Emirates Nigeria USA India Canada Qatar Russian Federation Turkey Germany Germany South Africa USA USA USA Switzerland Sw

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

d Arab Emirates Abdel-Wadood Rafik Ben Minister of Foreign Affairs of Tunisia Abdessalem Mohd Razali Abdul Chairman Peremba Group of Companies Malaysia Rahman Khalid Honorary Chairman Vision 3 United Arab Emirates Abdulla-Janahi Abdullah II Ibn Al King of the Hashemite Kingdom of Hussein Jo

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

rising from, or in connection with, the document. Japan: JPMorgan Securities Japan Co., Ltd. is regulated by the Financial Services Agency in Japan. Malaysia: This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bu

truda label further reinforces our view that Opdivo will maintain a clear leadership position in the NSCLC marketplace. Overall, we continue to see Merck as a competitive I/O player with a lead in multiple tumors with large unmet need such as HNSCC and colorectal tumors harboring MMR mutations. • Ke